Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B(100) in patients with T2DM

BACKGROUND: Apolipoprotein B(100) (ApoB(100)) determination is superior to low-density lipoprotein cholesterol (LDL-C) to establish cardiovascular (CV) risk, and does not require prior fasting. ApoB(100) is rarely measured alongside standard lipids, which precludes comprehensive assessment of dyslip...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601994/
https://www.ncbi.nlm.nih.gov/pubmed/23446247
http://dx.doi.org/10.1186/1475-2840-12-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601994/
https://www.ncbi.nlm.nih.gov/pubmed/23446247
http://dx.doi.org/10.1186/1475-2840-12-39

Ejemplares similares